Hong Kong Insurance Stock News

Pop Mart International Group (SEHK:9992) saw its shares rise by 3.15% over the last quarter, a period marked by key developments like its inclusion in both the Hang Seng Index and the Hang Seng China Enterprises Index on September 8, 2025. This addition underscores the company's growing prominence following impressive financial results reported on August 19, 2025, which showed significant year-over-year gains in sales and net income. During this time, major indices like the S&P 500 and Nasdaq...

Akeso (SEHK:9926) recently captured attention by presenting promising data on its cadonilimab therapy at the World Conference on Lung Cancer, highlighting its potential as a breakthrough treatment for immunotherapy-resistant non-small cell lung cancer. Over the last quarter, the company's share price surged 40%, potentially influenced by these significant clinical developments and the awarding of Breakthrough Therapy Designation. The broader market trend, which saw indices like the S&P 500...

Ascletis Pharma (SEHK:1672) recently announced noteworthy advancements related to its investigational drug ASC30, showcasing a promising 75-day half-life in a clinical study, which propelled excitement around potential once-quarterly administration for obesity management. As a result, the company's share price increased by nearly 48% over the last quarter. This rise occurred against a backdrop of broader market gains, with indexes like the Nasdaq and S&P 500 reaching all-time highs,...

Innovent Biologics (SEHK:1801) has recently been part of a significant client announcement, with a new partnership with Fangzhou Inc. aimed at integrating digital health services into innovative therapies for metabolic diseases. This event coincided with the company's share price rising 23% over the last quarter. Aside from this strategic move, the company has also witnessed FDA approval for key investigational drugs such as IBI363, adding weight to its impressive price performance. However,...

Following the recent announcements, Yunfeng Financial Group (SEHK:376) has seen a substantial share price surge of 108% over the past month. The company's impressive earnings announcement on August 28, 2025, which reported a substantial increase in net income to HKD 486 million from HKD 201 million, aligns with market enthusiasm that contributed to the broader market uptrend. Additionally, the new strategic partnership with Ant Digital Technologies and the investment in Pharos Network...

New World Development (SEHK:17) experienced a significant price surge of 66% over the last quarter, likely influenced by its recent strategic discussions to potentially sell its flagship 11 Skies mall for between HKD 15 billion (USD 1.9 billion) amid liquidity pressures. Additionally, the resignation of Dr. Cheng Chi-Kong, Adrian, as a non-executive director may have added to the volatility. These developments occurred alongside broader market trends, where the S&P 500 and Nasdaq set all-time...

Great Eagle Holdings (SEHK:41) probably stands out on your watchlist if you’ve noticed its recent stock performance. While there’s no specific headline driving today’s move, the steady uptick in share price might still prompt investors to ask if something deeper is at play, especially in a market that is often quick to react to subtle changes. Sometimes, the absence of a clear event can spark even more curiosity around a stock’s underlying value and what the market might be sensing in...

Most readers would already be aware that BioDlink International's (HKG:1875) stock increased significantly by 18% over...

Key Insights Nongfu Spring's significant insider ownership suggests inherent interests in company's expansion 84% of...

As global markets navigate a complex landscape of fluctuating interest rates and economic signals, investors are increasingly exploring diverse opportunities across various sectors. Penny stocks, often associated with smaller or newer companies, continue to capture attention for their potential to offer growth opportunities despite the term being somewhat outdated. By focusing on financial strength and long-term potential, these stocks can present attractive prospects for those looking to...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Key Insights The projected fair value for CSPC Pharmaceutical Group is HK$16.41 based on 2 Stage Free Cash Flow to...

Towngas Smart Energy Company Limited's ( HKG:1083 ) price-to-earnings (or "P/E") ratio of 8.8x might make it look like...

Key Insights The considerable ownership by individual investors in Shanghai Bio-heart Biological Technology indicates...

Key Insights Expert Systems Holdings to hold its Annual General Meeting on 16th of September Salary of HK$2.37m is part...

Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock...

Key Insights Hao Tian International Construction Investment Group will host its Annual General Meeting on 16th of...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Key Insights Intron Technology Holdings' significant private companies ownership suggests that the key decisions are...

The Art Group Holdings Limited ( HKG:565 ) share price has done very well over the last month, posting an excellent...

PetroChina (SEHK:857) has been catching the eye of investors lately, making some wonder whether now is the time to reassess their position. Despite no major event making headlines, the stock’s recent moves have started to raise questions for anyone following the energy sector closely. Sometimes, as we know, those quieter stretches can offer their own signals and invite a closer look at whether the company’s fundamentals are being overlooked or fully appreciated by the market. Over the past...

Hang Seng Bank (SEHK:11) has been turning heads lately, and if you’re watching the stock, you may be wondering if this momentum is signaling something deeper or just sparking investor curiosity. Even without a headline-grabbing event as a trigger, it’s natural to ask whether the recent upward move is a reaction to shifting fundamentals or a routine market adjustment. Sometimes, lack of obvious news is itself an invitation to take a closer look, especially when the price action seems to...

WuXi Biologics (Cayman) (SEHK:2269) has drawn fresh interest from investors after its latest move, though there are no headline-making events driving the shift. Sometimes, it is these quieter periods that leave investors asking if the market is overlooking a story or simply waiting for a new catalyst. This recent stretch of calm could be consequential for those weighing whether to stay the course or take a fresh look at their holdings. Looking at the share price performance, WuXi Biologics...

Ping An Healthcare and Technology (SEHK:1833) is once again attracting attention as investors digest its recent stock performance and the evolving health tech landscape in China. While there has been no headline-grabbing event driving moves this week, the company’s momentum and underlying fundamentals have many wondering if there is more beneath the surface. For anyone considering what to do next—whether to hold on, sell, or take the plunge—the current environment is setting an interesting...